3-(2-Thienyl)-DL-alanine is a DL-form amino acid derivative featuring an alanine backbone bearing a 2-thienyl (thiophene) substituent on the side chain, making it a non-proteinogenic, aromatic side-chain analogue of alanine. The molecule contains a free amino group and a free carboxyl group, and it is present as a racemic mixture (DL), which affects stereochemical composition in peptide incorporation and analytical behavior. As a substituted amino acid, it is used in peptide synthesis and structure-activity or binding studies to introduce a thiophene-containing aromatic side chain that can participate in hydrophobic and π-interaction patterns while providing a chemically defined handle for constructing more complex amino acid and peptide derivatives.
3-(2-Thienyl)-DL-alanine is a DL (racemic) amino acid bearing a 2-thienyl substituent at the 3-position, combining an amino acid backbone with a heteroaromatic side chain. This structure makes it a useful chiral and heteroaryl building block for medicinal chemistry and peptidomimetic design, where aromatic electronics and heteroaromatic geometry are leveraged to tune binding interactions and physicochemical properties. As a racemate, it is commonly selected for early-stage structure-activity relationship (SAR) work and for downstream resolution or stereochemical evaluation by researchers developing heteroaryl-containing analogs.
1. Peptidomimetic Building Block
3-(2-Thienyl)-DL-alanine is used by medicinal chemistry and chemical biology teams to construct peptidomimetic scaffolds and heteroaryl-substituted analogs that emulate amino acid side-chain presentation. The 2-thienyl group provides a compact aromatic/heteroaromatic motif that can participate in π-interactions and shape-dependent binding features, while the amino acid functionality supports incorporation into amide-linked structures and other amino-acid-derived frameworks. In practical workflows, the racemic DL form is often employed during early SAR rounds to quickly access a family of analogs before committing to stereochemically pure variants.
2. Pharmaceutical Intermediate Synthesis
3-(2-Thienyl)-DL-alanine serves as a heteroaryl-containing amino acid intermediate for the preparation of substituted amide, ester, and heteroaryl-bearing fragments used in small-molecule and macrocycle synthesis. Process and R&D chemists value this scaffold because it carries both the amino acid handle for functional group interconversion and the 2-thienyl moiety that can be retained through key transformations to deliver final intermediates for further elaboration. This makes the compound a practical starting material when developing routes to thiophene-substituted pharmacophores, including analog series where the heteroaryl unit is a defining structural element.
3. SAR Library Development
3-(2-Thienyl)-DL-alanine is frequently used to generate compound libraries for SAR studies in discovery chemistry, especially when a heteroaryl side chain is required to probe structure-property relationships. Researchers incorporate this amino acid building block into analogs where the thienyl substituent is expected to influence lipophilicity, aromatic surface contribution, and electronic character, while the amino acid-derived connectivity enables systematic variation of adjacent substituents. Because the material is provided as a DL racemate, it supports rapid parallel synthesis and screening, with stereochemical effects typically assessed later through separation or conversion to enantiopure derivatives when warranted by the data.
4. Chiral Resolution Feedstock
3-(2-Thienyl)-DL-alanine is also used as a starting feedstock for chiral resolution and stereochemical evaluation workflows in intermediate development. Teams that require enantiopure material for downstream synthesis often begin with a racemic amino acid building block to streamline procurement and route development, then apply resolution or stereoselective transformations to obtain the desired enantiomer for final analog production. The presence of a defined heteroaryl side chain ensures that the stereochemical outcome is assessed on the same structural platform, which is particularly valuable when stereochemistry is expected to modulate binding or conformational preferences in heteroaryl-containing series.
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More